This Solicitation opportunity from Department Of Veterans Affairs was posted on January 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505--Carbidopa Levodopa Immediate Release (IR) Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) number 36E79726R0008 for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets. This acquisition is unrestricted and will support multiple federal health agencies including VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Centers (FHCC). The contract will cover a one-year base period with four additional one-year option periods, aiming to ensure a continuous and reliable supply of the medication. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation, adhering to commercial item acquisition procedures under FAR Part 12, will be released electronically on or about December 18, 2025, with proposals due by January 8, 2026. Offerors must submit electronically via SAM.gov, as no paper copies or telephone requests for solicitation documents are permitted. The procurement encompasses multiple dosage strengths and packaging configurations of Carbidopa Levodopa IR Tablets, including 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg combinations in bottles containing 100, 500, or 1,000 tablets. Estimated annual requirements exceed 300,000 bottles across these formulations and packaging options, with key stipulations that each drug product be supplied under the exact labeled name with a unique National Drug Code (NDC) associated solely with the successful contractor. Over-labeling of existing manufacturer labels is explicitly prohibited. The contract will be awarded to a single responsible offeror capable of maintaining an uninterrupted supply chain. Labeling, packaging, and inspection will comply with FDA requirements but no additional military packaging standards or specialized preservation criteria are mandated. Administrative oversight is based out of the VA National Acquisition Center in Hines, Illinois, with Ray Roldan serving as the primary contracting specialist contact. The solicitation includes mutually exclusive line items for equivalent packaging options, though pricing information is not provided in this presolicitation notice and will be submitted by offerors during the proposal phase. All communications, amendments, and documentation will be handled electronically via SAM.gov, ensuring transparency and accessibility throughout the procurement process.
General Info
Contract Value
$0Place of Performance
ILSet-Aside
Awardee
XLCARE PHARMACEUTICALS INCAward Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
